News & Updates
Filter by Specialty:
Olaparib-abiraterone combo improves PFS in mCRPC
16 Mar 2022
byRoshini Claire Anthony
The combination of olaparib and abiraterone in the first-line setting improved radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC), results of the phase III PROpel trial showed.
Olaparib-abiraterone combo improves PFS in mCRPC
16 Mar 2022
Roxadustat proven safe, effective for anaemia in CKD patients
16 Mar 2022
Treatment with roxadustat leads to significant improvements in renal anaemia among patients with chronic kidney disease (CKD) by increasing haemoglobin (Hb) level and iron metabolism, according to a recent study. However, the risk of serious adverse events (AEs) during treatment must be considered.
Roxadustat proven safe, effective for anaemia in CKD patients
16 Mar 2022
Thrombectomy safe for paediatric stroke patients
16 Mar 2022
In the treatment of children with acute ischaemic stroke, endovascular thrombectomy is safe and results in high rates of achieving favourable functional outcomes, as shown in a study.